Technetium-99m stannous pyrophosphate scintigrams in normal subjects, patients with exercise-induced ischemia and patients with a calcified valve

• Published in: The American journal of cardiology Vol. 39; no. 3; pp. 360 - 363
• Main Authors: Klein, Milton S., Weiss, Alan N., Roberts, Robert, Coleman, R. Edward
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.1977
• Subjects: Adult; Aged; Calcinosis - diagnosis; Coronary Disease - diagnosis; Female; Heart Valve Diseases - diagnosis; Humans; Male; Metabolic Clearance Rate; Middle Aged; Myocardium - metabolism; Physical Exertion; Technetium - blood
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/S0002-9149(77)80089-1

Although technetium-99m stannous ( 99mTc[Sn]) pyrophosphate has been shown to be a specific and sensitive index of myocardial infarction, abnormal images have been reported in patients with unstable angina or ventricular aneurysm. Sixty-one subjects—33 patients subjected to maximal treadmill stress testing, 23 normal subjects and 5 patients with a calcified aortic or mitral valve—underwent imaging with 99mTc(Sn) pyrophosphate to determine whether abnormal images are associated with (1) exercise-induced ischemia, (2) delayed clearance of tracer from the blood pool, or (3) calcified intracardiac structures. Myocardial injury was excluded on the basis of normal MB creatine kinase (CK) values in all patients with stress testing. All eight patients with an abnormal exercise stress test had normal images. Four of 25 patients with a normal exercise stress test had diffusely abnormal images. In some normal subjects diffusely abnormal images were present 60 minutes after injection of the tracer, but became normal 90 to 120 minutes after injection. Variations in clearance of tracer from the blood pool were noted in this group. Patients with a calcified aortic or mitral valve had normal images. We conclude that (1) exercise-induced ischemia is not associated with abnormal 99mTc(Sn) pyrophosphate images; (2) images are not necessarily abnormal in patients with a calcified valve; and (3) delayed removal of tracer from the cardiac blood pool may result in diffusely abnormal images even in normal subjects; in these cases, repeat images should be obtained at least 2 hours after injection of the tracer to avoid false abnormal images.